

![]() |
Transient gadolinium leakage in natalizumab-treated multiple sclerosis |
|
Authors | ||
Published in | Journal of neurology, neurosurgery and psychiatry. 2015, vol. 86, no. 4, p. 475-6 | |
Keywords | Antibodies, Monoclonal, Humanized/adverse effects — Contrast Media/adverse effects — Extravasation of Diagnostic and Therapeutic Materials/etiology — Gadolinium/adverse effects — Humans — Magnetic Resonance Imaging — Multiple Sclerosis, Relapsing-Remitting/complications/drug therapy — Natalizumab | |
Identifiers | PMID: 25246642 | |
Full text | ||
Structures | ||
Research groups | Ischémie cérébrale et connectivité (801) Scléroses en plaques, neuroimmunologie, encéphalite autoimmune expérimentale (843) | |
Citation (ISO format) | HALLER, Sven et al. Transient gadolinium leakage in natalizumab-treated multiple sclerosis. In: Journal of neurology, neurosurgery and psychiatry, 2015, vol. 86, n° 4, p. 475-6. doi: 10.1136/jnnp-2014-309069 https://archive-ouverte.unige.ch/unige:89944 |